Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin.
about
Plasminogen activator inhibitor-1 promotes inflammatory process induced by cigarette smoke extraction or lipopolysaccharides in alveolar epithelial cellsWNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosisDual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healingLethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.Interaction of late apoptotic and necrotic cells with vitronectin.Epithelial repair mechanisms in the lungPlasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.Control of fibroblast fibronectin expression and alternative splicing via the PI3K/Akt/mTOR pathwayFrom evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest.The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.Regulation of alveolar epithelial cell apoptosis and pulmonary fibrosis by coordinate expression of components of the fibrinolytic systemAltered bladder function in elastin-deficient mice at baseline and in response to partial bladder outlet obstruction.Epithelial-mesenchymal interactions in pulmonary fibrosis.Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapyPAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury.Macrophages programmed by apoptotic cells inhibit epithelial-mesenchymal transition in lung alveolar epithelial cells via PGE2, PGD2, and HGFInflammatory levels of nitric oxide inhibit airway epithelial cell migration by inhibition of the kinase ERK1/2 and activation of hypoxia-inducible factor-1 alpha.Truncated Plasminogen Activator Inhibitor-1 Protein Protects From Pulmonary Fibrosis Mediated by Irradiation in a Murine Model.PAI-1 inhibits neutrophil efferocytosis.Regulation of lung injury and fibrosis by p53-mediated changes in urokinase and plasminogen activator inhibitor-1.Validation of the vitronectin knockout mouse as a model for studying myocardial infarction: Vitronectin appears to influence left ventricular remodelling following myocardial infarction.Inter-alpha-trypsin inhibitor promotes bronchial epithelial repair after injury through vitronectin bindingPlasminogen activator inhibitor-1 does not contribute to the pulmonary pathology induced by acute exposure to ozone.PAI-1 in tissue fibrosis.SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-cateninThe vitronectin RGD motif regulates TGF-β-induced alveolar epithelial cell apoptosis.Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosisThe inhibitory effect of ginsan on TGF-β mediated fibrotic process.Plasminogen activation induced pericellular fibronectin proteolysis promotes fibroblast apoptosis.Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis.Erectile dysfunction in the type II diabetic db/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix.The human airway trypsin-like protease modulates the urokinase receptor (uPAR, CD87) structure and functions.
P2860
Q24317592-846EE1A4-FB50-42D2-BD12-8F6446C85C00Q24650922-95E192A7-4C28-497D-9513-0952C19E5374Q28580473-FD2FF379-3168-4501-BA67-43D37465B56CQ30407311-CCC7DF3F-5FF7-44A6-AC71-346600E3EFFBQ33900891-8E60E362-8528-4C0F-B85C-9ABB55D74DDEQ33916933-9F335B5B-956E-4BBC-9738-120B868DCCA9Q34021916-B8299BB3-8DAE-4E44-91DF-238EE82D7B2CQ34077087-2DEA0BDA-0C85-40CE-B8B3-2CF27BB9069CQ34528902-AED42F90-29BA-4AF2-AEAF-F6F7CF222628Q35182731-38F1B683-84FB-465F-AFD5-E3937ABE2937Q35850241-C61BA95A-F098-4019-96B9-3B9454C4ECA9Q35881737-4E530081-0E2F-4EBF-A79E-17CD206AB27BQ36427136-3E67B929-3634-45CD-BE5C-E43BADFEE9ACQ36440438-C347954B-6BF7-4F81-8320-94AA97B6276DQ36486253-11034008-38FD-4C3F-B9C9-A3BE5EDBA455Q36579632-85AD5146-111D-463E-A94D-5A70F0B230ABQ36737519-587BFFF9-126C-417C-8C15-4ED112ADCFBCQ36819764-04A77B7E-B094-478D-A6C9-5FC7E0DD7EC1Q36954409-FC5587E2-3E7D-4CB9-A861-BEF968375768Q36986513-B295DEC3-ABB3-4B69-A7C9-06F2F7B9D3A8Q37027536-3BFBED96-AB42-4BD7-BF00-B91BBA02C1E8Q37285073-F9D7BE05-908C-4C6B-B6C6-294A695286AFQ37286847-BC009FC4-EF22-4D5D-B402-CE0FF20919FDQ37861626-0BB726F3-4A44-4693-9E05-66A9795FFC65Q39431361-4D3BEA43-2580-4A85-A39F-D7025939E1DFQ39829197-28B02A47-DCCA-4E29-B793-17B7EB48747FQ41973656-072C1671-5926-480E-A129-D7F16F203BC3Q42002715-A758F3D5-6BAC-4F0F-AB15-143438BE7DC9Q42819484-C115CB71-7791-427F-9DD7-B3791EC24BABQ42921010-73823ECA-D1F4-496B-BE2A-054604B7FFADQ45888374-D66EB4F2-EECD-4AFD-B751-587BB45DB01FQ46713746-0DF5D053-FDD4-40BF-B840-770C1B4FDB40Q53576300-C4CF58BC-57E8-455F-B526-578DB92B6389
P2860
Plasminogen activator inhibitor-1 impairs alveolar epithelial repair by binding to vitronectin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Plasminogen activator inhibito ...... air by binding to vitronectin.
@en
type
label
Plasminogen activator inhibito ...... air by binding to vitronectin.
@en
prefLabel
Plasminogen activator inhibito ...... air by binding to vitronectin.
@en
P2093
P2860
P356
P1476
Plasminogen activator inhibito ...... air by binding to vitronectin.
@en
P2093
Jean M Hansen
Kerstin E Hanson
Michael H Lazar
Natalya M Subbotina
Paul J Christensen
Richard H Simon
Thomas H Sisson
P2860
P304
P356
10.1165/RCMB.2004-0025OC
P577
2004-08-12T00:00:00Z